SCHEMBL18890701

SCHEMBL18890701

C/C=C(\C)Nc1cc(C)cc(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 4/20 0.47
GAA P10253 2/20 0.47
NPSR1 Q6W5P4 2/20 0.42
HTT P42858 1/20 0.42
THRB P10828 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18890669 0.76 TDP1 (0.58) MEN1KMT2AMAPTHTTCYP1A2
SCHEMBL19429663 0.74 MEN1 (0.42) MEN1KMT2AMAPTGAANPSR1
SCHEMBL849875 0.73 MEN1 (0.77) MEN1KMT2AMAPTGAANPSR1
SCHEMBL18570378 0.73 MEN1 (0.48) MEN1KMT2AMAPTGAANPSR1
SCHEMBL15478107 0.73 GAA (0.59) MEN1KMT2AMAPTGAANPSR1
SCHEMBL19005463 0.71 RAB9A (0.46) MEN1KMT2AMAPTGAANPSR1
SCHEMBL93283 0.70 NPSR1 (0.55) MEN1KMT2AMAPTGAANPSR1
SCHEMBL15484245 0.70 MAPT (0.75) MEN1KMT2AMAPTGAANPSR1
SCHEMBL27923493 0.70 MEN1 (0.73) MEN1KMT2AMAPTGAANPSR1
Methyl Alcohol SCHEMBL28397318 0.69 ALDH1A1 (0.64) MAPTGAALMNACYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657004-B2 Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use AGIOS PHARMACEUTICALS, INC (US) 2017-05-23 US disclosed